Business Analysis for Diabetic Products

Diabetes has become a matter of huge concern as it is a cosmopolitan disorder with an estimated 285 million diabetic, corresponding to 6.4 percentage of world’s adult population, are living with diabetes. The diabetic population is expected to explode to 438 million by 2030, corresponding to 7.8 percentage of the adult population. The rate of this disorder is on it’s highest at increase. As it is a leading problem globally there is also a gigantic demand for the diagnosis and screening, medication. The global type 2 diabetes market is set to almost double from $31.2 billion in 2015 to $58.7 billion by 2025, representing a compound annual growth rate of 6.5%, according to research and consulting firm Global Data.

The pharmaceutical business is attaining a top places in this field of medication.   

  • Insulin biosimilars development
  • Novel paradigms

Related Conference of Business Analysis for Diabetic Products

May 08-09, 2025

5th European Endocrinology and Diabetes Congress

Madrid, Spain
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland
July 29-30, 2025

15th World Congress on Endocrinology and Diabetes

Paris, France
September 08-09, 2025

3rd World congress and Expo on Diabetes

Frankfurt, Germany
October 30-31, 2025

5th Annual Summit on Diabetes and Endocrinology

Paris, France
November 06-07, 2025

8th Annual Meeting on Diabetes and Endocrinology

Dubai, UAE
November 20-21, 2025

21st World Congress on Endocrinology & Diabetes

Paris, France
March 26-27, 2026

7th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands

Business Analysis for Diabetic Products Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in